Related Experiment Video
Updated: Jun 25, 2025

Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry
Published on: September 13, 2014
Michaelis-like complex of mouse ketohexokinase isoform C
William C Gasper1, Sarah Gardner2, Adam Ross2
1Program in Biochemistry and Molecular Biology, Boston University, Boston, MA 02215, USA.
Ketohexokinase (KHK) is crucial for fructose metabolism and related diseases. This study presents a high-resolution structure of mouse KHK-C bound to fructose and ADP, revealing conformational changes important for catalysis and potential therapeutic targeting.
Area of Science:
- Biochemistry and Structural Biology
- Metabolic Disease Research
Background:
- Rising incidence of fructose-related diseases like obesity, heart disease, and diabetes over the past 40 years.
- Ketohexokinase (KHK) is a key enzyme in liver fructolysis, catalyzing fructose phosphorylation.
- Understanding KHK's structure-function relationship is vital for developing therapeutic inhibitors.
Purpose of the Study:
- To elucidate the molecular mechanism of Ketohexokinase (KHK) through high-resolution structural analysis.
- To investigate the structure-function relationship of KHK in ligand binding and catalysis.
- To assess the suitability of mouse models for studying KHK-related diseases and therapeutic strategies.
Main Methods:
- High-resolution X-ray crystallography of mouse KHK-C (mKHK-C) at 1.79 Å resolution.
- Determination of the enzyme's structure in a complex with substrate (fructose) and product (ADP).
- Comparison of structural data with unliganded forms to understand conformational changes.
Main Results:
- A high-resolution crystal structure of mKHK-C in a Michaelis-like complex with fructose and ADP was determined.
- Binding of substrates induces a significant conformational change, with a β-sheet domain rotating to form a lid over the active site.
- Mouse and human KHK enzymes exhibit similar kinetic parameters, validating mice as a relevant model for KHK-related disease research.
Conclusions:
- The determined structure provides insight into the catalytic mechanism of KHK-C, highlighting the role of conformational changes.
- The structural and kinetic similarities between mouse and human KHK support the use of mouse models in preclinical studies.
- This molecular understanding is foundational for designing targeted KHK inhibitors to combat fructose-related metabolic diseases.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Electron Transport Chain: Complex III and IV
Determination of Michaelis Constant and Maximum Elimination Rate
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
The Supercomplexes in the Crista Membrane
Enzyme Kinetics
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
Conjugate Addition of Enolates: Michael Addition

